NCT06491680View on ClinicalTrials.gov

Cardiotoxicity in Breast Cancer Patients

PHASE4RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

June 30, 2026

Conditions
Breast Cancer
Interventions
DRUG

Dapagliflozin 10mg Tab

"Dapagliflozin 10 mg tablet orally, once daily. Started 7 days before the first cycle of anthracyclines till the end of last anthracyclines dose.~taken orally, once daily. Started from 5 to 7 days before the first cycle of anthracyclines till the end of last anthracycline dose."

Trial Locations (1)

202

RECRUITING

Al demerdash hospital at oncology departement, Cairo

All Listed Sponsors
lead

Helwan University

OTHER

NCT06491680 - Cardiotoxicity in Breast Cancer Patients | Biotech Hunter | Biotech Hunter